Efficacy and Safety of Miltefosine in Antihistamine Resistant Chronic Urticaria

NCT01170949 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

76

Enrollment

OTHER

Sponsor class

Stopped Study medication expired

Conditions

Chronic Urticaria

Interventions

DRUG: Miltefosine
DRUG: Placebo

Sponsor

Marcus Maurer

Collaborators

[object Object]